Polypropylene Production

Research & Development

Lummus Technology operates a Research & Development (R&D) center for polypropylene technology at the BASF Verbund site in Germany, where laboratory preparation and semi-commercial product application and testing are conducted. These facilities are state-of-the-art, having the added advantage of access to special test methods and the infrastructure of the BASF site. The center is staffed with an international team of highly-qualified scientists, product experts and laboratory technicians who are able to constantly improve each aspect of our technology.
 

Catalyst Development

One aspect of our R&D comprises the development, synthesis and testing of new polymerization catalysts in the areas of Ziegler-Natta catalysts and Metallocene catalysts. A number of modern automated autoclave systems are available for direct catalyst testing.
 

Product Development and Analytics

We are very active in the field of product development and, with our laboratory equipment, we are in the position to test each aspect of our newly developed products. When it comes to detailed polymer analytics, state-of-the-art analytical equipment for liquid/gas chromatography, mass spectrometry, fourier transform infrared spectroscopy, x-ray fluorescence spectroscopy, NMR spectroscopy, etc., is available.

In addition, we are prepared to assist our licensees in analyzing products in detail at any time.
 

Process Development

The Novolen technology gas-phase process is always in the focus of optimization and development. Such developments include the reduction of operating costs (OPEX) and capital investments (CAPEX), the optimization of process control and a strong commitment on all safety-related functions of the process. Following recent R&D activities, several independent consultants have concluded that our advanced gas-phase process is presently the most competitive with respect to OPEX and CAPEX, and it offers the easiest operability. As a non-producing licensor, we are able to make improvements available to all licensees without any restrictions.